ADRENERGIC LIMITATION OF CORONARY FLOW DURING EXERCISE

运动期间肾上腺素能对冠状动脉血流的限制

基本信息

项目摘要

Previous studies under this grant indicate that an alpha-constrictor tone limits myocardial perfusion and as a result imposes a limitation on myocardial contractile function. Because of the potential importance of this adrenergic effect on coronary perfusion and myocardial function during physical exertion in the human, four new studies are proposed. Research studies by others suggest that the alpha-constriction is mediated by circulating catecholamines rather than to neural mechanisms, while pilot studies from this laboratory indicate that neural mechanisms play a large role. Therefore, Study 5 will examine whether the coronary alpha- constrictor tone is mediated primarily humoral or by neural mechanisms. Studies also conflict with regard to the transmural distribution of an alpha-constrictor tone and its physiological importance in modulating myocardial blood flow. Study 6 will examine the transmural nature of he adrenergic constrictor tone and its effect on transmural myocardial function during exercise. Studies by others have shown that during progressive coronary occlusion, there is a reduction in flow leading to a reduction in contractile function long before the coronary dilatory reserve capacity is exhausted. Study 7 will examine whether the alpha-constrictor tone varies with the intensity of exercise, and whether the constrictor tone, as a result of restricting coronary flow also imposes a limitation on maximal cardiac performance at maximal levels of exercise. The specific alpha-receptor subtypes involved will also be examined. Pilot studies indicate that holding flow constant during mild exercise induces a sympathetic vasoconstriction. Therefore, Study 8 will examine whether ischemia during exercise elicits a neural reflex which imposes a coronary alpha-constriction. These important studies will be applicable to the treatment of the human with pre-existing coronary artery disease, especially during exertion.
先前的研究表明,这是一种阿尔法收缩音

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patricia A. Gwirtz其他文献

Patricia A. Gwirtz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patricia A. Gwirtz', 18)}}的其他基金

CARDIOVASCULAR ADAPTATIONS TO RENOVASCULAR HYPERTENSION
心血管对肾血管性高血压的适应
  • 批准号:
    2909118
  • 财政年份:
    1999
  • 资助金额:
    $ 13.89万
  • 项目类别:
CARDIOVASCULAR ADAPTATIONS TO RENOVASCULAR HYPERTENSION
心血管对肾血管性高血压的适应
  • 批准号:
    6078844
  • 财政年份:
    1998
  • 资助金额:
    $ 13.89万
  • 项目类别:
CARDIOVASCULAR ADAPTATIONS TO RENOVASCULAR HYPERTENSION
心血管对肾血管性高血压的适应
  • 批准号:
    2453305
  • 财政年份:
    1998
  • 资助金额:
    $ 13.89万
  • 项目类别:
CARDIOVASCULAR ADAPTATIONS TO RENOVASCULAR HYPERTENSION
心血管对肾血管性高血压的适应
  • 批准号:
    6139271
  • 财政年份:
    1998
  • 资助金额:
    $ 13.89万
  • 项目类别:
CARDIOVASCULAR ADAPTATIONS TO RENOVASCULAR HYPERTENSION
心血管对肾血管性高血压的适应
  • 批准号:
    2857947
  • 财政年份:
    1998
  • 资助金额:
    $ 13.89万
  • 项目类别:
CARDIOVASCULAR ADAPTATIONS TO RENOVASCULAR HYPERTENSION
心血管对肾血管性高血压的适应
  • 批准号:
    6343603
  • 财政年份:
    1998
  • 资助金额:
    $ 13.89万
  • 项目类别:
ADRENERGIC LIMITATION OF CORONARY FLOW DURING EXERCISE
运动期间肾上腺素能对冠状动脉血流的限制
  • 批准号:
    3346860
  • 财政年份:
    1990
  • 资助金额:
    $ 13.89万
  • 项目类别:
ADRENERGIC LIMITATION OF CORONARY FLOW DURING EXERCISE
运动期间肾上腺素能对冠状动脉血流的限制
  • 批准号:
    3346855
  • 财政年份:
    1990
  • 资助金额:
    $ 13.89万
  • 项目类别:
ADRENERGIC LIMITATION OF CORONARY FLOW DURING EXERCISE
运动期间肾上腺素能对冠状动脉血流的限制
  • 批准号:
    2028189
  • 财政年份:
    1990
  • 资助金额:
    $ 13.89万
  • 项目类别:
ADRENERGIC LIMITATION OF CORONARY FLOW DURING EXERCISE
运动期间肾上腺素能对冠状动脉血流的限制
  • 批准号:
    2217468
  • 财政年份:
    1990
  • 资助金额:
    $ 13.89万
  • 项目类别:

相似海外基金

MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6110455
  • 财政年份:
    1999
  • 资助金额:
    $ 13.89万
  • 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6273039
  • 财政年份:
    1998
  • 资助金额:
    $ 13.89万
  • 项目类别:
MOLECULAR BASIS OF ALPHA ADRENERGIC RECEPTOR FUNCTION
α 肾上腺素能受体功能的分子基础
  • 批准号:
    6242449
  • 财政年份:
    1997
  • 资助金额:
    $ 13.89万
  • 项目类别:
Central and renal alpha-adrenergic receptor with the development of salt-induced hypertension in Dahl-Iwai salt-sensitive rats.
中枢和肾脏 α-肾上腺素能受体与 Dahl-Iwai 盐敏感大鼠中盐诱导高血压的发展。
  • 批准号:
    03670461
  • 财政年份:
    1991
  • 资助金额:
    $ 13.89万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402353
  • 财政年份:
    1984
  • 资助金额:
    $ 13.89万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402355
  • 财政年份:
    1984
  • 资助金额:
    $ 13.89万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    2264148
  • 财政年份:
    1984
  • 资助金额:
    $ 13.89万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402348
  • 财政年份:
    1984
  • 资助金额:
    $ 13.89万
  • 项目类别:
ALPHA-ADRENERGIC RECEPTOR BINDING
α-肾上腺素能受体结合
  • 批准号:
    3402354
  • 财政年份:
    1984
  • 资助金额:
    $ 13.89万
  • 项目类别:
IDENTIFICATION AND FUNCTION OF ALPHA-ADRENERGIC RECEPTOR
α-肾上腺素能受体的鉴定和功能
  • 批准号:
    3079007
  • 财政年份:
    1983
  • 资助金额:
    $ 13.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了